APYX
APYX
NASDAQ · Health Care

Apyx Medical Corp

$2.65
-0.16 (-5.69%)
Financial Highlights (FY 2026)
Revenue
51.36M
Net Income
-10,894,992
Gross Margin
62.5%
Profit Margin
-21.2%
Rev Growth
+5.9%
D/E Ratio
2.40
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 62.5% 62.5% 36.7% 36.7%
Operating Margin -12.2% -11.0% 18.0% 17.4%
Profit Margin -21.2% -20.2% 11.0% 13.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 51.36M 48.50M 88.82M 91.82M
Gross Profit 32.11M 30.33M 32.57M 33.67M
Operating Income -6,265,411 -5,325,214 16.01M 15.98M
Net Income -10,894,992 -9,260,074 9.74M 12.10M
Gross Margin 62.5% 62.5% 36.7% 36.7%
Operating Margin -12.2% -11.0% 18.0% 17.4%
Profit Margin -21.2% -20.2% 11.0% 13.2%
Rev Growth +5.9% +5.9% -9.1% +17.8%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 40.73M 40.73M 11.75M 11.58M
Total Equity 16.98M 16.98M 90.85M 91.27M
D/E Ratio 2.40 2.40 0.13 0.13
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -5,627,215 -5,048,497 18.03M 21.54M
Free Cash Flow — — 4.63M 6.18M